ASH 2023: Hematology players ready for big showcase

With the end of the year approaching, it is again time for The American Society of Hematology (ASH) Annual Meeting, the last major pharmaceutical conference in the calendar.

The major players in this fast-moving field are ready to impress with their datasets, so The Pharma Letter has taken a look at some of the highlights of what is to come.

Analyst Evaluate has predicted that two big themes–CAR-T safety and sickle cell disease–will dominate this year’s event, but plenty of companies will seek to steal the show in San Diego across different disease types.